ES529175A0 - Procedimiento para la preparacion de derivados de imidazol - Google Patents

Procedimiento para la preparacion de derivados de imidazol

Info

Publication number
ES529175A0
ES529175A0 ES529175A ES529175A ES529175A0 ES 529175 A0 ES529175 A0 ES 529175A0 ES 529175 A ES529175 A ES 529175A ES 529175 A ES529175 A ES 529175A ES 529175 A0 ES529175 A0 ES 529175A0
Authority
ES
Spain
Prior art keywords
procedure
preparation
imidazole derivatives
imidazole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES529175A
Other languages
English (en)
Other versions
ES8500242A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of ES8500242A1 publication Critical patent/ES8500242A1/es
Publication of ES529175A0 publication Critical patent/ES529175A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES529175A 1982-07-01 1984-01-26 Procedimiento para la preparacion de derivados de imidazol Granted ES529175A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823224512 DE3224512A1 (de) 1982-07-01 1982-07-01 Neue imidazolderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
ES8500242A1 ES8500242A1 (es) 1984-10-01
ES529175A0 true ES529175A0 (es) 1984-10-01

Family

ID=6167285

Family Applications (3)

Application Number Title Priority Date Filing Date
ES523709A Expired ES8500056A1 (es) 1982-07-01 1983-06-30 Procedimiento para la preparacion de derivados de imidazol.
ES529174A Granted ES529174A0 (es) 1982-07-01 1984-01-26 Procedimiento para la preparacion de derivados de imidazol
ES529175A Granted ES529175A0 (es) 1982-07-01 1984-01-26 Procedimiento para la preparacion de derivados de imidazol

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES523709A Expired ES8500056A1 (es) 1982-07-01 1983-06-30 Procedimiento para la preparacion de derivados de imidazol.
ES529174A Granted ES529174A0 (es) 1982-07-01 1984-01-26 Procedimiento para la preparacion de derivados de imidazol

Country Status (23)

Country Link
US (2) US4582837A (es)
EP (1) EP0098448A3 (es)
JP (1) JPS5927875A (es)
KR (1) KR840005432A (es)
AU (1) AU1642883A (es)
CS (1) CS254319B2 (es)
DD (1) DD210271A5 (es)
DE (1) DE3224512A1 (es)
DK (1) DK301383A (es)
ES (3) ES8500056A1 (es)
FI (1) FI832022A7 (es)
GB (1) GB2122995B (es)
GR (1) GR78598B (es)
HU (1) HU192152B (es)
IL (1) IL69111A0 (es)
NO (1) NO832356L (es)
NZ (1) NZ204766A (es)
PH (1) PH20810A (es)
PL (2) PL142880B1 (es)
PT (1) PT76968B (es)
SU (2) SU1316559A3 (es)
YU (1) YU143283A (es)
ZA (1) ZA834777B (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES517193A0 (es) * 1981-11-10 1983-12-01 Wellcome Found Un procedimiento para la preparacion de nuevos derivados de imidazo (4,5-c)piridina.
US4758574A (en) * 1982-05-03 1988-07-19 Eli Lilly And Company 2-phenylimidazio (4,5-c) pyridines
DE3324115A1 (de) * 1983-07-05 1985-01-17 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazole, ihre herstellung und diese verbindungen enthaltende arzneimittel
DE3346575A1 (de) * 1983-12-23 1985-07-04 Dr. Karl Thomae Gmbh, 7950 Biberach Neue benzimidazole, ihre herstellung und diese verbindungen enthaltende arzneimittel
GR850426B (es) * 1984-02-24 1985-06-18 Lilly Co Eli
GR851085B (es) * 1984-05-12 1985-11-25 Boehringer Mannheim Gmbh
EP0178413A1 (en) * 1984-08-17 1986-04-23 Beecham Group Plc Benzimidazoles
LU85544A1 (fr) * 1984-09-19 1986-04-03 Cird Derives heterocycliques aromatiques,leur procede de preparation et leur application dans les domaines therapeutique et cosmetique
DE3445299A1 (de) * 1984-12-12 1986-06-19 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3445669A1 (de) * 1984-12-14 1986-06-19 Boehringer Mannheim Gmbh, 6800 Mannheim Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3501497A1 (de) * 1985-01-18 1986-07-24 Boehringer Mannheim Gmbh, 6800 Mannheim Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
DE3522230A1 (de) * 1985-06-21 1987-01-02 Thomae Gmbh Dr K Neue 2-arylimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
NZ217755A (en) * 1985-10-09 1989-08-29 Chemie Linz Ag 2-(2-thienyl)-imidazo(4,5-c)pyridine derivatives and pharmaceutical compositions
GB8804016D0 (en) * 1988-02-22 1988-03-23 Boots Co Plc Therapeutic agents
DE4027592A1 (de) * 1990-08-31 1992-03-05 Beiersdorf Ag Neue pyrrolobenzimidazole, imidazobenzoxazinone und imidazochinolone, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen
US5466704A (en) * 1991-02-26 1995-11-14 E. R. Squibb & Sons, Inc. N-substituted imidazole and benzimidazole derivatives useful as angiotenson II antagonists
FR2677020B1 (fr) * 1991-05-31 1993-08-27 Cird Galderma Composes derives de benzimidazole, leur procede de preparation et leur utilisation dans les domaines therapeutique et cosmetique.
US6919366B2 (en) * 1998-05-22 2005-07-19 Avanir Pharmaceuticals Benzimidazole derivatives as modulators of IgE
US6911462B2 (en) * 1998-05-22 2005-06-28 Avanir Pharmaceuticals Benzimidazole compounds for regulating IgE
EE200100323A (et) 1998-12-18 2002-08-15 Axys Pharmaceuticals, Inc. (Hetero)arüüli - bitsüklilise heteroarüüli derivaadid, nende valmistamine ja nende kasutamine proteaasiinhibiitoritena
GB9914825D0 (en) * 1999-06-24 1999-08-25 Smithkline Beecham Spa Novel compounds
TWI225488B (en) * 1999-12-21 2004-12-21 Janssen Pharmaceutica Nv Derivatives of homopiperidinyl substituted benzimidazole analogues
DE10015866A1 (de) 2000-03-30 2001-10-11 Bayer Ag Aryl- und Heteroarylsulfonate
CA2412462A1 (en) 2000-06-14 2001-12-20 Warner-Lambert Company 6,5-fused bicyclic heterocycles
ES2291455T3 (es) * 2001-03-12 2008-03-01 Avanir Pharmaceuticals Compuestos de bencimidazol para modular ige e inhibir la proliferacion celular.
AU2003211942A1 (en) * 2002-02-14 2003-09-04 Shionogi And Co., Ltd. Process for production of 2,3-diaminopyridine derivatives
TW200304820A (en) * 2002-03-25 2003-10-16 Avanir Pharmaceuticals Use of benzimidazole analogs in the treatment of cell proliferation
WO2004024655A2 (en) 2002-09-12 2004-03-25 Avanir Pharmaceuticals Phenyl-indole compounds for modulating ige and inhibiting cellular proliferation
TWI276631B (en) * 2002-09-12 2007-03-21 Avanir Pharmaceuticals Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
AU2004263190A1 (en) * 2003-08-08 2005-02-17 Avanir Pharmaceuticals Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases
US7449481B2 (en) * 2004-04-13 2008-11-11 Cephalon, Inc. Thio-substituted biaryl-methanesulfinyl derivatives
US20090149452A1 (en) * 2005-07-01 2009-06-11 Nippon Chemiphar Co., Ltd. Xanthine oxidase inhibitor
BRPI0616994A2 (pt) * 2005-08-15 2011-07-05 Irm Llc compostos e composições como miméticos de tpo
CN101479249B (zh) * 2006-06-29 2012-10-10 霍夫曼-拉罗奇有限公司 苯并咪唑衍生物、其制备方法、它们作为fxr激动剂的用途及含有它们的药物制剂
TW200831472A (en) * 2006-11-30 2008-08-01 Wyeth Corp Process for the synthesis of monosulfated derivatives of substituted benzoxazoles
US7816540B2 (en) * 2007-12-21 2010-10-19 Hoffmann-La Roche Inc. Carboxyl- or hydroxyl-substituted benzimidazole derivatives
WO2014151729A1 (en) 2013-03-15 2014-09-25 Irm Llc Compounds and compositions for the treatment of parasitic diseases
US9296754B2 (en) 2013-03-15 2016-03-29 Novartis Ag Compounds and compositions for the treatment of parasitic diseases
US9233961B2 (en) 2013-03-15 2016-01-12 Novartis Ag Compounds and compositions for the treatment of parasitic diseases
MY175865A (en) 2013-12-19 2020-07-14 Novartis Ag [1,2,4]triazolo[1,5-a]pyrimidine derivatives as protozoan proteasome inhibitors for the treatment of parasitic diseases such as leishmaniasis
AR099677A1 (es) * 2014-03-07 2016-08-10 Sumitomo Chemical Co Compuesto heterocíclico fusionado y su uso para el control de plagas
CN108290884A (zh) * 2015-11-16 2018-07-17 先正达参股股份有限公司 具有含硫取代基的杀有害生物活性杂环衍生物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2305339C3 (de) * 1973-02-03 1980-05-08 Dr. Karl Thomae Gmbh, 7950 Biberach Imidazo [4,5-b] pyridine, ihre Herstellung und ihre Verwendung als Cardiötonica
US3985891A (en) * 1973-02-03 1976-10-12 Boehringer Ingelheim Gmbh 2-Phenyl-imidazo (4,5-b)pyridines and salts thereof
DE2927987A1 (de) * 1979-07-11 1981-02-05 Thomae Gmbh Dr K Neue 2-alkoxyphenyl-imidazo eckige klammer auf 4,5-b eckige klammer zu pyridine, deren herstellung und deren verwendung als arzneimittel
DE2927988A1 (de) * 1979-07-11 1981-02-05 Thomae Gmbh Dr K Neue 8-phenyl-purine, deren herstellung und deren verwendung als arzneimittel
JPS5721375A (en) * 1980-07-14 1982-02-04 Yamanouchi Pharmaceut Co Ltd 2,6-di-tert-butyl-4-heterocyclic substituted phenolic derivative and its preparation
EP0072926B1 (de) * 1981-08-19 1986-09-24 MERCK PATENT GmbH 2-Aryl-imidazopyridine
ES517193A0 (es) * 1981-11-10 1983-12-01 Wellcome Found Un procedimiento para la preparacion de nuevos derivados de imidazo (4,5-c)piridina.

Also Published As

Publication number Publication date
DE3224512A1 (de) 1984-01-05
ES8500242A1 (es) 1984-10-01
AU1642883A (en) 1984-01-05
SU1179924A3 (ru) 1985-09-15
FI832022A0 (fi) 1983-06-06
GR78598B (es) 1984-09-27
SU1316559A3 (ru) 1987-06-07
DK301383A (da) 1984-01-02
GB2122995B (en) 1986-02-12
ES523709A0 (es) 1984-10-01
ES8500241A1 (es) 1984-10-01
PL242770A1 (en) 1986-10-21
ZA834777B (en) 1985-03-27
PT76968B (de) 1986-04-09
YU143283A (en) 1986-06-30
PH20810A (en) 1987-04-24
DD210271A5 (de) 1984-06-06
ES8500056A1 (es) 1984-10-01
HU192152B (en) 1987-05-28
FI832022L (fi) 1984-01-02
DK301383D0 (da) 1983-06-30
PL144589B1 (en) 1988-06-30
PL142880B1 (en) 1987-12-31
ES529174A0 (es) 1984-10-01
CS254319B2 (en) 1988-01-15
US4696931A (en) 1987-09-29
IL69111A0 (en) 1983-10-31
NO832356L (no) 1984-01-02
KR840005432A (ko) 1984-11-12
JPS5927875A (ja) 1984-02-14
FI832022A7 (fi) 1984-01-02
EP0098448A2 (de) 1984-01-18
PT76968A (de) 1983-07-01
GB8317732D0 (en) 1983-08-03
EP0098448A3 (de) 1985-04-03
NZ204766A (en) 1986-09-10
GB2122995A (en) 1984-01-25
US4582837A (en) 1986-04-15

Similar Documents

Publication Publication Date Title
ES529174A0 (es) Procedimiento para la preparacion de derivados de imidazol
ES504257A0 (es) Procedimiento para la obtencion de derivados de imidazol trisustituidos
ES526807A0 (es) Procedimiento para la preparacion de nuevas hidantoinas
ES526899A0 (es) Procedimiento para la preparacion de nuevos bencimidazoles substituidos
ES525803A0 (es) Procedimiento para la obtencion de derivados de feniletilamina
ES524997A0 (es) Procedimiento para la preparacion de derivados de la desoxiuridina
ES528181A0 (es) Procedimiento para la obtencion de derivados de imidazol (i,5-a)-piridina
ES554732A0 (es) Procedimiento para la obtencion de nuevos derivados del tieno (2,3-d) imidazol
ES551472A0 (es) Un procedimiento para la preparacion de derivados de imidazol triciclicos
ES543286A0 (es) Procedimiento para preparar nuevos derivados de imidazol
ES530042A0 (es) Procedimiento para la obtencion de derivados de imidazol conteniendo azufre
ES534337A0 (es) Procedimiento para la preparacion de derivados de acridanona
ES525034A0 (es) Procedimiento para la preparacion de derivados de 28-metil-brassinolidas
ES549981A0 (es) Procedimiento para preparar derivados de imidazol con acti- vidad antitrombotica
ES501700A0 (es) Procedimiento para la preparacion de derivados de imidazol
ES529963A0 (es) Procedimiento para la preparacion de un compuesto de imidazol
ES530681A0 (es) Procedimiento para preparar derivados de (indenil-2)-2-imidazolina
ES505322A0 (es) Procedimiento para la preparacion de derivados de imidazol
ES504523A0 (es) Procedimiento para la preparacion de composiciones a base desalicilato de imidazol
IT1164222B (it) Procedimento per la preparazione di o-fenilendiammina
ES536137A0 (es) Procedimiento para la obtencion de derivados de triazolilmetil-piridiloximetil-carbinoles
ES525035A0 (es) Procedimiento para la preparacion de derivados de brassinoesteroides
DK421583A (da) Fremgangsmaade til fremstilling af imidazolinderivater
MX155447A (es) Procedimiento de preparacion de derivados de la pirrolidina
MX154894A (es) Procedimiento para la preparacion de derivados de fenilciclobutilaminas